Entasis Therapeutics Holdings Inc. Aktie
Aktien
A2N4R0
US2936141033
ETTX
Biotechnologie
Manager | Titel | Alter | Seit |
---|---|---|---|
Manoussos Perros
CEO | Chief Executive Officer | 56 | 01.05.15 |
Ruben Tommasi
CTO | Chief Tech/Sci/R&D Officer | 58 | 01.05.15 |
David Altarac
CTO | Chief Tech/Sci/R&D Officer | 63 | 04.11.19 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
David Hastings
BRD | Director/Board Member | 62 | 01.04.18 |
Director/Board Member | 58 | 01.08.17 | |
Heather Behanna
BRD | Director/Board Member | 49 | 01.08.17 |
% 1. Jan. | Kap. | |
---|---|---|
-2.31% | 103 Mrd. | |
+0.56% | 95.71 Mrd. | |
+1.69% | 22.02 Mrd. | |
-17.37% | 20.9 Mrd. | |
-9.30% | 17.85 Mrd. | |
-41.01% | 16.21 Mrd. | |
-14.85% | 15.52 Mrd. | |
+3.21% | 13.86 Mrd. | |
+33.54% | 12.04 Mrd. |